2013
DOI: 10.1016/j.biomaterials.2012.10.062
|View full text |Cite
|
Sign up to set email alerts
|

Hydrogels derived from central nervous system extracellular matrix

Abstract: Biologic scaffolds composed of extracellular matrix (ECM) are commonly used repair devices in preclinical and clinical settings; however the use of these scaffolds for peripheral and central nervous system (CNS) repair has been limited. Biologic scaffolds developed from brain and spinal cord tissue have recently been described, yet the conformation of the harvested ECM limits therapeutic utility. An injectable CNS-ECM derived hydrogel capable of in vivo polymerization and conformation to irregular lesion geome… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
246
1
2

Year Published

2013
2013
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 243 publications
(258 citation statements)
references
References 48 publications
9
246
1
2
Order By: Relevance
“…Recent work has described the potential benefits of ECM scaffold materials derived from homologous tissue versus heterologous tissue when used in selected anatomic locations. 2,[4][5][6][7][8][9][10][11] The homologous ECM can preferentially maintain tissuespecific cell phenotypes, [4][5][6][7] promote cell proliferation, 6,8 induce tissue-specific differentiation, 9 and enhance the chemotaxis of stem cells. 2,10,12 However, the preference or necessity for tissue-specific ECM has not been shown for all therapeutic applications.…”
mentioning
confidence: 99%
“…Recent work has described the potential benefits of ECM scaffold materials derived from homologous tissue versus heterologous tissue when used in selected anatomic locations. 2,[4][5][6][7][8][9][10][11] The homologous ECM can preferentially maintain tissuespecific cell phenotypes, [4][5][6][7] promote cell proliferation, 6,8 induce tissue-specific differentiation, 9 and enhance the chemotaxis of stem cells. 2,10,12 However, the preference or necessity for tissue-specific ECM has not been shown for all therapeutic applications.…”
mentioning
confidence: 99%
“…In cultured N1E-115 neuroblastoma cells, brain ECM was shown to promote neurite growth, an effect that was not evident in cells treated with spinal cord ECM or UBM. 15 ECM derived from the CNS also facilitates the differentiation of NSCs into neurons, while UBM does not have a significant impact. 26 In the present study, we demonstrate the therapeutic effects of brain ECM in an animal model of TBI, with some longterm histological protection and functional improvements.…”
Section: Discussionmentioning
confidence: 99%
“…Several combination ECM materials isolated from mammalian sources are commercially available [52,77] , while others are in various stages of development and characterization [19,[78][79][80] .…”
Section: Polymersmentioning
confidence: 99%
“…Recently, several groups have started to isolate ECM from CNS to study its potential as a regenerative substrate for SCi [80,85] . Table 2.…”
Section: Polymersmentioning
confidence: 99%